Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$193.75 - $232.55 $23,443 - $28,138
-121 Reduced 11.28%
952 $221,000
Q4 2022

Feb 08, 2023

SELL
$187.24 - $242.74 $12,732 - $16,506
-68 Reduced 5.96%
1,073 $216,000
Q3 2022

Nov 14, 2022

SELL
$177.23 - $227.44 $70,714 - $90,748
-399 Reduced 25.91%
1,141 $217,000
Q2 2022

Aug 04, 2022

SELL
$181.58 - $368.0 $79,350 - $160,816
-437 Reduced 22.1%
1,540 $283,000
Q1 2022

May 12, 2022

SELL
$303.87 - $423.8 $238,537 - $332,683
-785 Reduced 28.42%
1,977 $692,000
Q4 2021

Feb 11, 2022

SELL
$347.28 - $421.83 $71,886 - $87,318
-207 Reduced 6.97%
2,762 $1.08 Million
Q3 2021

Nov 15, 2021

BUY
$405.61 - $524.84 $658,710 - $852,340
1,624 Added 120.74%
2,969 $1.21 Million
Q2 2021

Aug 11, 2021

SELL
$372.84 - $481.5 $3,728 - $4,815
-10 Reduced 0.74%
1,345 $636,000
Q1 2021

May 07, 2021

SELL
$361.28 - $504.76 $15,535 - $21,704
-43 Reduced 3.08%
1,355 $520,000
Q4 2020

Feb 09, 2021

SELL
$292.7 - $370.96 $585 - $741
-2 Reduced 0.14%
1,398 $517,000
Q3 2020

Nov 02, 2020

BUY
$268.51 - $400.74 $31,147 - $46,485
116 Added 9.03%
1,400 $432,000
Q2 2020

Aug 10, 2020

SELL
$256.46 - $373.01 $33,083 - $48,118
-129 Reduced 9.13%
1,284 $475,000
Q1 2020

May 05, 2020

SELL
$209.2 - $335.53 $22,802 - $36,572
-109 Reduced 7.16%
1,413 $385,000
Q4 2019

Feb 06, 2020

BUY
$288.29 - $335.49 $213,334 - $248,262
740 Added 94.63%
1,522 $504,000
Q3 2019

Nov 07, 2019

BUY
$266.84 - $378.23 $32,020 - $45,387
120 Added 18.13%
782 $237,000
Q1 2019

May 07, 2019

SELL
$272.57 - $321.18 $10,902 - $12,847
-40 Reduced 5.7%
662 $205,000
Q3 2018

Nov 06, 2018

BUY
$279.04 - $367.06 $195,886 - $257,676
702 New
702 $257,000
Q3 2017

Nov 13, 2017

SELL
$172.3 - $213.93 $286,362 - $355,551
-1,662 Closed
0 $0
Q2 2017

Aug 09, 2017

BUY
N/A
1,662
1,662 $280,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.9B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Gerber Kawasaki Wealth & Investment Management Portfolio

Follow Gerber Kawasaki Wealth & Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber Kawasaki Wealth & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Gerber Kawasaki Wealth & Investment Management with notifications on news.